Evaluation of the effect of Mutramargata Uttararabasti(Intravesical Drug Administration) with Shudhha Bala Taila on the Quality of Life of Cystocele patients

Evaluation of the change in Quality of Life of Cystocele Patients through Mutramarga Gata Uttarabasti with Shuddha Bala Taila- An Exploratory Study

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039573

Enrollment

Registered

2022-01-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N811- Cystocele

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical symptoms of cystocele 2.Patients diagnosed with grade I and grade II cystocele with or without urethrocele 3.Patients willing to participate in the study and willing to give written consent.

Exclusion criteria

Exclusion criteria: 1.Patients with severe systemic disorders 2.Pregnant females 3.Patients having malignancy 4.Patients having third degree uterine prolapse (Procidentia) 5.Known cases of sexually transmitted diseases and acute UTI 6.Uttarabasti Anarha 7.Patients with urethral stricture

Design outcomes

Primary

Measure	Time frame
1.Improvement in the Quality of Life of Cystocele patients through P-QOL Status. 2.Improvement in the clinical Symptoms of Cystocele.Timepoint: 0th Day, 7th Day, 22nd Day	—

Secondary

Measure	Time frame
1.Reduction in the scores of UDI- 6, IIQ-7, POPDI-6 scales. 2.Improvement in Pelvic Organ Prolapse Quantification grading scale. 3.Finding a possible correlation of Cystocele in Ayurveda. Timepoint: 0th Day, 7th Day, 22nd Day	—

Countries

India

Contacts

Public ContactDr Prasanth Dharmarajan

All India Institute of Ayurveda

dr.ananthramsharma@gmail.com9495130595

Outcome results